Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Cardiac PET Stories

2012-08-22 10:24:31

LUBBOCK, Texas, Aug. 22, 2012 /PRNewswire/ -- Positron Corporation, (OTCBB:POSC) a leading molecular imaging healthcare company, is pleased to announce the submission of a Drug Master File (DMF), with the Federal Drug Administration (FDA), for the production of Active Pharmaceutical Ingredient (API) grade strontium-82, through its wholly owned subsidiary Manhattan Isotope Technology, LLC. A Drug Master File (DMF) is a document submitted to the FDA, which contains complete information on an...

2012-08-20 06:28:15

CHICAGO, Aug. 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company, is pleased to announce the FDA's marketing approval of The University of Texas Health Science Center at Houston (UTHealth) Coronary Flow Reserve (CFR) quantification software, cfrQuant(TM). The cfrQuant(TM) software was developed under the guidance of K. Lance Gould, M.D., and the Weatherhead PET Imaging Center of the UTHealth Medical School, with contributions of...

2012-08-16 06:24:59

CHICAGO, Aug. 16, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company is pleased to announce the use of their Attrius system at Caring Heart and Brain Imaging Inc., of Manasquan, New Jersey, which now offers Amyvid PET scans to identify the presence of plaque in the brain, which has been shown to be a precursor to Alzheimer's disease. Amyvid(TM) (Florbetapir F-18 Injection) is indicated for Positron Emission Tomography (PET) imaging of the...

2012-07-20 06:22:25

GARY, Ind., July 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, announces approval of a Pledge Resolution for $15 Million in Tax Increment Financing (TIF) Bonds, from the Redevelopment Commission of the City of Gary, Indiana towards the development of Positron's 70 MeV cyclotron project. In addition to the TIF incentives, the City of Gary will assist in sourcing the appropriate allocation of New Market Tax Credits (NMTC) that could...

2012-06-11 20:36:33

New molecular imaging technique compensates for breathing and heartbeat to deliver highest-quality images of the heart A development in 4D image reconstruction compensates for blurring caused by the beating of the heart, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting. The new method provides sharper-than-ever images of cardiac function to help pinpoint heart defects for better diagnoses and treatment. Cardiovascular disease is the number one killer across the...

2012-06-05 06:29:06

LUBBOCK, Texas, June 5, 2012 /PRNewswire/ -- Positron Corporation a leading molecular imaging healthcare company, specializing in the field of nuclear cardiology announces completion of its first strontium validation effort. In May 2012, Manhattan Isotope Technology (MIT), a Positron subsidiary, successfully processed strontium. The internal analysis of the product demonstrates it meets the Sr-82 purity specifications required for the formulation of Sr-82/Rb-82 generators. MIT has now...

2012-01-27 12:46:00

FISHERS, Ind., Jan. 27, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, specializing in the field of nuclear cardiology, is pleased to announce that on January 23, 2012, its wholly owned subsidiary, Manhattan Isotope Technology (MIT), received approval of its radioactive materials license amendment. The Texas Department of State Health Services- Radiation Control Program granted the amendment approval. This specific...

2012-01-17 09:13:00

FISHERS, Ind., Jan. 17, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce the acquisition of Manhattan Isotope Technology, LLC (MIT). Positron has acquired all of the assets, business operations and retained all employees of MIT. In exchange, MIT shall receive cash advances, assumption of certain indebtedness and earn-out consideration of $3,500,000 based on 20 percent...

2011-12-14 13:04:00

FISHERS, Ind., Dec. 14, 2011 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce today that on December 12, 2011, the Company's Positron Emission Tomography Scanner(s) Attrius & Attrius L have received approval for sale in Canada. The Medical Device License from Health Canada was granted to the Attrius systems manufacturer, Neusoft Positron Medical Systems. NPMS is a joint venture...

2010-11-10 03:30:00

DALLAS, November 10, 2010 /PRNewswire/ -- The report analyzes the PET SPECT Market ( http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html) by technologies and applications and studies the major market drivers, restraints, and opportunities for the PET SPECT market in U.S., EMEA, and Asia-Pacific. Browse market data tables and in-depth TOC on Advanced PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Global Market (2010 -2015)...